Right Heart Contrast Echocardiography Microbubble Count and Migraine Severity: A Dose-Effect Relationship Study

右心造影超声心动图微泡计数与偏头痛严重程度:剂量效应关系研究

阅读:1

Abstract

OBJECTIVE: This study aimed to investigate whether a dose-effect relationship exists between the number of microbubbles detected on right heart contrast echocardiography (RHCE) and the clinical severity of migraine. METHODS: We conducted a cross-sectional study of 190 adult patients diagnosed with migraine who underwent RHCE. Microbubble counts were categorized into four grades per frame (Grades 0-III) based on their appearance in the left atrium within three to six cardiac cycles after right atrial opacification. Migraine severity was assessed using the Migraine Disability Assessment (MIDAS) score and the Headache Impact Test (HIT-6). Multivariate linear regression was used to evaluate the association between microbubble grades and migraine severity. The predictive ability of the model was assessed using the residual plots and variance inflation factors. Sensitivity analyses were performed to test the robustness of the findings by adjusting for potential confounders. RESULTS: A clear dose-response relationship was identified, with patients in higher microbubble-grade groups demonstrating significantly elevated MIDAS and HIT-6 scores (p < 0.001). Patients with Grade III microbubbles reported the highest mean MIDAS (18.2 ± 6.1) and HIT-6 (64.8 ± 4.9) scores, compared to those in lower grades (p < 0.001). Regression analyses confirmed that the higher microbubble burden independently predicted migraine severity (β = 0.46, p < 0.001). Sensitivity analyses yielded consistent findings. CONCLUSION: Our results suggest a notable dose-effect relationship between RHCE microbubble count and migraine severity. These findings highlight the potential role of right-to-left shunting as a physiological contributor to migraine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。